Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Nanning
Clinical trial register · China

Clinical Trials in Nanning, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 09 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Nanning 23 Liuzhou 7 Guigang 5 Guilin 5 Wuzhou 5
Narrow the registerReset
Recruitment status
Phase
Site location
Nanning23 Liuzhou7 Guigang5 Guilin5 Wuzhou5
All 18 locations
Target enrolment
to

Trials with a site in Nanning

23 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
CascadeDiagnose Prostate MRI
NCT07844304Prostate Cancer (Diagnosis)
First Affiliated Hospital of Guangxi Medical University
Observational
3,000
Guigang, Guilin, Liuzhou, Nanning, Wuzhou
2026-10-01
Not yet open
Federated Learning in Renal Tumor Model
NCT07841756Renal Tumors
First Affiliated Hospital of Guangxi Medical University
Observational
3,000
Guigang, Guilin, Liuzhou, Nanning, Wuzhou
2026-10-01
Recruiting
First Affiliated Hospital of Guangxi Medical University
Phase 3
352
Xiamen, Guangzhou, Baise City, Chongzuo, Guigang, Laibin, Liuzhou, Nanning
2026-09-24
Not yet open
First Affiliated Hospital of Guangxi Medical University
Observational
500
Nanning
2026-09-01
Not yet open
Impacted Tooth Management and Osteoradionecrosis Risk in NPC
NCT07764887Nasopharyngeal Carcinoma (NPC), Osteoradionecrosis of the Jaw
First Affiliated Hospital of Guangxi Medical University
Not applicable
536
Baise City, Beihai, Guigang, Guilin, Liuzhou, Nanning, Wuzhou, Yulin
2026-08-30
Not yet open
An International Multicenter Clinical Study on Application of UroMed AI Doctor Based on Large Language Models
NCT07555756Kidney Calculi, Prostatic Hyperplasia, Urinary Bladder Neoplasms
First Affiliated Hospital of Guangxi Medical University
Not applicable
1,080
Nanning
2026-05-01
Not yet open
Multi-Site Cortical Puncture for DOR
NCT07568639Diminished Ovarian Reserve (DOR)
First Affiliated Hospital of Guangxi Medical University
Not applicable
214
Xiamen, Guigang, Liuzhou, Nanning, Qinzhou
2026-04-30
Recruiting
First Affiliated Hospital of Guangxi Medical University
Observational
392
Nanning
2026-03-22
Recruiting
First Affiliated Hospital of Guangxi Medical University
Phase 3
266
Nanning
2026-03-05
Not yet open
First Affiliated Hospital of Guangxi Medical University
Phase 2
200
Nanning
2026-01
Not yet open
Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer
NCT07132008Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University
Phase 3
94
Nanning
2025-10-01
Recruiting
First Affiliated Hospital of Guangxi Medical University
Not applicable
318
Nanning
2025-07-22
Not yet open
First Affiliated Hospital of Guangxi Medical University
Observational
50
Nanning
2025-06-30
Recruiting
First Affiliated Hospital of Guangxi Medical University
Observational
500
Nanning, Qinzhou, Wuzhou, Yulin, Suzhou
2025-01-06
Not yet open
First Affiliated Hospital of Guangxi Medical University
Phase 2
150
Nanning
2024-11
Recruiting
The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer
NCT06254521Rectal Cancer, Rectal Cancer Stage II, Rectal Cancer Stage III
First Affiliated Hospital of Guangxi Medical University
Phase 2
60
Nanning
2024-02-22
Active, closed
Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer
NCT06124378Colonic Neoplasms, Neoadjuvant Therapy, Immune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University
Phase 2
60
Nanning
2023-11-13
Recruiting
First Affiliated Hospital of Guangxi Medical University
Not applicable
190
Fuzhou, Guangzhou, Huizhou, Guilin, Liuzhou, Nanning, Wuzhou, Yulin
2023-06-12
Recruiting
First Affiliated Hospital of Guangxi Medical University
Phase 1
5
Nanning
2023-05-08
Recruiting
First Affiliated Hospital of Guangxi Medical University
Early Phase 1
5
Nanning
2023-02-22
Recruiting
First Affiliated Hospital of Guangxi Medical University
Phase 2
112
Nanning
2022-09-01
Recruiting
First Affiliated Hospital of Guangxi Medical University
Not applicable
50
Nanning
2022-01-15
Rows per page Showing 1–23 of 23
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 November 2026. https://priyalifescience.com/clinical-trials-china/city/nanning

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 09 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 23 of those studies with a site in Nanning that also match the filters currently applied.

How many clinical trials are recruiting in Nanning?

11 of the 23 studies on this page are recruiting new participants as of the 09 Nov 2026, 03:17 UTC sync. A further 11 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nanning), 23 studies
PhaseStudiesRecruitingShare
Not applicable6326.1%
Observational6226.1%
Phase 26226.1%
Phase 33213%
Early Phase 1114.3%
Phase 1114.3%

Most active sponsors

Lead sponsors with the most studies (Nanning)
Lead sponsorStudiesRecruiting
First Affiliated Hospital of Guangxi Medical University2311
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.